Edited by:
Markus A Rüegg: Biozentrum, University of Basel, Switzerland
Carmen Birchmeier: Max Delbrück Center for Molecular Medicine, Germany
David J. Glass: Regeneron Pharmaceuticals, USA
Skeletal Muscle is calling for submissions to our new Collection on "Gene Therapy in Skeletal Muscle and Neuromuscular Diseases".
Image credit: Ilya Lukichev / Getty Images / iStock
Gene therapies are thought to be transformative treatments for monogenetic diseases. Recent years have seen a huge progress in their use in human patients with many ongoing clinical trials and a few treatments approved. A particular focus of such efforts are diseases that affect skeletal muscle and the neuromuscular system. However, there are also challenges to the field, such as the high dose of viral vectors needed, the insufficient targeting of skeletal muscle and possible immune reactions to the transgene. This collection will discuss many of those aspects and will highlight the measures taken to overcome these challenges.
There are currently no articles in this collection.
Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Gene Therapy in Skeletal Muscle and Neuromuscular Diseases" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.